Open AccessRisk of Contralateral Breast Cancer in Women with Ductal Carcinoma In Situ Associated with Synchronous Ipsilateral Lobular Carcinoma In Situ
Author(s) -
Megan E. Miller,
Shirin Muhsen,
Emily C. Zabor,
Jessica Flynn,
Cristina Olcese,
Dilip Giri,
Kimberly J. Van Zee,
Melissa Pilewskie
Publication year - 2019
Publication title -
annals of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.764
H-Index - 173
eISSN - 1534-4681
pISSN - 1068-9265
DOI - 10.1245/s10434-019-07796-9
Subject(s) - medicine , ductal carcinoma , breast cancer , lobular carcinoma , hazard ratio , cumulative incidence , oncology , carcinoma in situ , carcinoma , confidence interval , gynecology , cancer , cohort
Lobular carcinoma in situ (LCIS) is a risk factor for breast cancer, but the effect of LCIS found in association with ductal carcinoma in situ (DCIS) is unknown. In this study, we compared contralateral breast cancer (CBC) and ipsilateral breast tumor recurrence (IBTR) rates among women with DCIS with or without synchronous ipsilateral LCIS treated with breast-conserving surgery (BCS).